Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
Cinzia Bottino, Alessia Peserico, Cristiano Simone, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 142-142
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 124
SMYD3: a regulator of epigenetic and signaling pathways in cancer
Benjamin Bernard, Nupur Nigam, Kyunghee Burkitt, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Approaching the catalytic mechanism of protein lysine methyltransferases by biochemical and simulation techniques
Philipp Schnee, Jürgen Pleiss, Albert Jeltsch
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 20-68
Open Access | Times Cited: 5
Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
Alyssa Padilla, John F. Manganaro, Lydia Huesgen, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 2000-2000
Open Access | Times Cited: 12
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair
Yujia Huang, Ming Tang, Zhi‐Yi Hu, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis
Brunna Letícia Olivera Santana, Mariana Braccialli de Loyola, Ana Cristina Moura Gualberto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6097-6097
Open Access | Times Cited: 4
Histone methyltransferase Smyd3 is a new regulator for vascular senescence
Di Yang, Gang Wei, Fen Long, et al.
Aging Cell (2020) Vol. 19, Iss. 9
Open Access | Times Cited: 28
Functions of SMYD proteins in biological processes: What do we know? An updated review
Ascensión Rueda‐Robles, Matteo Audano, Ana I. Álvarez‐Mercado, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 712, pp. 109040-109040
Closed Access | Times Cited: 27
The function of histone methylation and acetylation regulators in GBM pathophysiology
Colin McCornack, Timothy Woodiwiss, Angela Hardi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Direct lysine dimethylation of IRF3 by the methyltransferase SMYD3 attenuates antiviral innate immunity
Zixuan Wang, Xiaoyun Chen, Chunchun Zhu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 3
Open Access
Integrated computational and biosensor-based strategies for the discovery of allosteric SMYD3 ligands using diperodon as a starting point
Edward A. Fitzgerald, Moira Rachman, Daniela Cederfelt, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118134-118134
Open Access
Epigenetic insights into prostate cancer: exploring histone modifications and their therapeutic implications
Bunty Sharma, Himanshu Shekhar, Anidrisha Sahu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
SMYD3 as an Epigenetic Regulator of Renal Tubular Cell Survival and Regeneration Following Acute Kidney Injury in Mice
Xin‐Yu Du, Fengchen Shen, Chao Yu, et al.
The FASEB Journal (2025) Vol. 39, Iss. 9
Closed Access
An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
Yuhao Zhao, Yang Mao, Shijia Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
Zongcheng Yang, Fen Liu, Li Zongkai, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
The homeoprotein HOXB2 limits triple-negative breast carcinogenesis via extracellular matrix remodeling
Ji Hoon Oh, Clara Yuri Kim, Da Som Jeong, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 1045-1063
Open Access | Times Cited: 3
Ensemble Simulations and Experimental Free Energy Distributions: Evaluation and Characterization of Isoxazole Amides as SMYD3 Inhibitors
Shunzhou Wan, Agastya P. Bhati, David W. Wright, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 10, pp. 2561-2570
Open Access | Times Cited: 14
SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription
Tian Tian, Jiwei Li, Di Shi, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 13
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
Paola Sanese, Candida Fasano, Giacomo Buscemi, et al.
iScience (2020) Vol. 23, Iss. 10, pp. 101604-101604
Open Access | Times Cited: 18
A SMYD3/ITGB6/TGFβ1 Positive Feedback Loop Promotes the Invasion and Adhesion of Ovarian Cancer Spheroids
Yahui Jiang, Tianyu Zhou, Yiwen Shi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
Marco Parenti, Marina Naldi, Elisabetta Manoni, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114683-114683
Closed Access | Times Cited: 11
Salidroside promotes healthy longevity by interfering with HSP90 activity
Jianfei Zhang, Zhiquan Li, Jiangbo Song, et al.
GeroScience (2023) Vol. 46, Iss. 2, pp. 1641-1655
Open Access | Times Cited: 6
Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cells
Paola Sanese, Candida Fasano, Martina Lepore Signorile, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189203-189203
Open Access | Times Cited: 2
Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes
Aldesia Provenzano, Andrea La Barbera, Mirko Scagnet, et al.
Human Genetics (2020) Vol. 140, Iss. 4, pp. 625-647
Open Access | Times Cited: 16
Methyltransferase SMYD3 impairs hypoxia tolerance by augmenting hypoxia signaling independent of its enzymatic activity
Zixuan Wang, Xiaoyun Chen, Sijia Fan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102633-102633
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top